Kopran Limited announced that Medicines & Healthcare products Regulatory Agency of United Kingdom (MHRA - UK) renewed GMP Compliance Certificate for Company's two plant at it's manufacturing site at Khopoli, District-Raigad, Maharashtra that it complies with the Principles and guidelines of Good Manufacturing practices laid down in Regulation B17 of the Human Medicines Regulations 2012 (as amended). This development illustrates the company's commitment to work closely with the MHRA-UK and strive for 100% cGMP Compliance at its manufacturing facilities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
254.9 INR | -1.96% | -0.97% | +5.59% |
1st Jan change | Capi. | |
---|---|---|
+5.59% | 147M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- KOPRAN Stock
- News Kopran Limited
- Kopran Limited Announces Renewal of Gmp Compliance Certificate by Medicines & Healthcare Products Regulatory Agency of United Kingdom (Mhra - Uk)